Gold nanostructure-mediated delivery of anti-cancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers.
暂无分享,去创建一个
A. Jebali | M. Hashemi | K. Hushmandi | M. Entezari | Y. N. Ertas | Hamidreza Saebfar | M. Rashidi | Seyedeh Sara Karimian | A. Taheriazam | Shokooh Salimimoghadam | R. Beiranvand | Mohammad Arad Zandieh | Shafagh Asadi | Ramin Khorrami | Reyhaneh Ettehadi | Ghazaleh Gholamiyan Yousef Abad | Behnaz Sedghi | Negar Haratian
[1] H. Nosrati,et al. Enhanced In Vivo Radiotherapy of Breast Cancer Using Gadolinium Oxide and Gold Hybrid Nanoparticles , 2023, ACS applied bio materials.
[2] Michael R Hamblin,et al. Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis. , 2023, Journal of controlled release : official journal of the Controlled Release Society.
[3] Farzad Seidi,et al. Preparation of alginate coated Pt nanoparticle for radiosensitization of breast cancer tumor. , 2023, International journal of biological macromolecules.
[4] M. Hashemi,et al. siRNA and targeted delivery systems in breast cancer therapy , 2022, Clinical and Translational Oncology.
[5] H. Danafar,et al. Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.
[6] A. Aref,et al. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation , 2022, Journal of Drug Delivery Science and Technology.
[7] R. Tekade,et al. CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells , 2022, Pharmaceutics.
[8] O. Kanoun,et al. Gold Nanoparticles-MWCNT Based Aptasensor for Early Diagnosis of Prostate Cancer , 2022, Biosensors.
[9] K. Asadpour‐Zeynali,et al. An ultrasensitive and preprocessing-free electrochemical platform for the detection of doxorubicin based on tryptophan/polyethylene glycol-cobalt ferrite nanoparticles modified electrodes , 2022, Microchemical Journal.
[10] Y. Badr,et al. Gold nanoparticles loaded chitosan encapsulate 6-mercaptopurine as a novel nanocomposite for chemo-photothermal therapy on breast cancer , 2022, BMC Chemistry.
[11] R. Blaheta,et al. Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro , 2022, Cancers.
[12] Jie Liu,et al. WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis , 2022, Frontiers in Pharmacology.
[13] S. Wilhelm,et al. Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth , 2022, Advanced science.
[14] J. Conde,et al. Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer. , 2022, Biomaterials advances.
[15] A. Ramazani,et al. Preparation and evaluation of Bismuth Sulfide and Magnetite based Theranostic Nanohybrid as Drug Carrier and Dual MRI/CT Contrast Agent , 2022, Applied Organometallic Chemistry.
[16] M. Mandal,et al. Gold Nanoparticle Embedded Stimuli-Responsive Functional Glycopolymer: A Potential Material for Synergistic Chemo-Photodynamic Therapy of Cancer Cells. , 2022, Macromolecular bioscience.
[17] V. V. Tatarskiy,et al. Suppression of PI3K/Akt/mTOR Signaling Pathway and Antioxidant System and Reversal of Cancer Cells Resistance to Cisplatin under the Effect of Curcumin , 2022, Bulletin of Experimental Biology and Medicine.
[18] Lingling Shan,et al. Amentoflavone-loaded nanoparticles enhanced chemotherapy efficacy by inhibition of AKR1B10 , 2022, Nanotechnology.
[19] Honglei Zhan,et al. Gold Nanoparticle-Decorated Drug Nanocrystals for Enhancing Anticancer Efficacy and Reversing Drug Resistance Through Chemo-/Photothermal Therapy. , 2022, Molecular pharmaceutics.
[20] Li Li,et al. Gold nanorods/tetrahedral DNA composites for chemo-photothermal therapy , 2022, Regenerative biomaterials.
[21] Nam-Ho Kim,et al. Sulforaphane Suppresses the Nicotine-Induced Expression of the Matrix Metalloproteinase-9 via Inhibiting ROS-Mediated AP-1 and NF-κB Signaling in Human Gastric Cancer Cells , 2022, International journal of molecular sciences.
[22] Youmie Park,et al. Folic Acid and Chitosan-Functionalized Gold Nanorods and Triangular Silver Nanoplates for the Delivery of Anticancer Agents , 2022, International journal of nanomedicine.
[23] Li-hui Wang,et al. An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer , 2022, Molecular cancer.
[24] Michael R Hamblin,et al. Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity , 2022, Journal of cellular physiology.
[25] Honglei Zhan,et al. A New Gold Nanoparticles and Paclitaxel Co-Delivery System for Enhanced Anti-Cancer Effect Through Chemo-Photothermal Combination. , 2022, Journal of biomedical nanotechnology.
[26] M. Coelho,et al. Nanocarriers Based on Gold Nanoparticles for Epigallocatechin Gallate Delivery in Cancer Cells , 2022, Pharmaceutics.
[27] H. Feng,et al. KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer. , 2022, Life sciences.
[28] S. Cheah,et al. Preparation and Characterization of Chitosan and Inclusive Compound-Layered Gold Nanocarrier to Improve the Antiproliferation Effect of Tamoxifen Citrate in Colorectal Adenocarcinoma (Caco-2) and Breast Cancer (MCF-7) Cells. , 2021, Turkish journal of pharmaceutical sciences.
[29] Hui-ying Yu,et al. Antibody-conjugated silica-coated gold nanoparticles in targeted therapy of cervical cancer. , 2022, American journal of translational research.
[30] Shu-Jyuan Yang,et al. The synergistic effect of chemo-photothermal therapies in SN-38-loaded gold-nanoshell-based colorectal cancer treatment. , 2021, Nanomedicine.
[31] A. Kwong,et al. Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer , 2021, Clinical and Translational Oncology.
[32] P. Ferreira,et al. HA/PEI-coated acridine orange-loaded gold-core silica shell nanorods for cancer-targeted photothermal and chemotherapy. , 2021, Nanomedicine.
[33] Masoud Delfi,et al. Advances in tannic acid-incorporated biomaterials: Infection treatment, regenerative medicine, cancer therapy, and biosensing , 2021, Chemical Engineering Journal.
[34] N. Zarghami,et al. Implantable magnetic nanofibers with ON-OFF switchable release of curcumin for possible local hyperthermic chemotherapy of melanoma. , 2021, Journal of biomedical materials research. Part A.
[35] Jae Hyun Kim,et al. Yolk-Shell-Type Gold Nanoaggregates for Chemo- and Photothermal Combination Therapy for Drug-Resistant Cancers. , 2021, ACS applied materials & interfaces.
[36] M. Ashrafizadeh,et al. Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence. , 2021, International journal of biological macromolecules.
[37] V. Mattoli,et al. Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking , 2021, Nano Today.
[38] Yonghong Sun,et al. Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance , 2021, Cell Death & Differentiation.
[39] F. Bahreini,et al. Anticancer Effects of Gold Nanoparticles by Inducing Apoptosis in Bladder Cancer 5637 Cells , 2021, Biological Trace Element Research.
[40] Qiang Liu,et al. Gold nanorods conjugated with biocompatible zwitterionic polypeptide for combined chemo-photothermal therapy of cervical cancer. , 2021, Colloids and surfaces. B, Biointerfaces.
[41] E. Jabbari,et al. Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells: A Review of Recent Advances , 2021, Nanomaterials.
[42] C. Su,et al. Peroxidase Mimetic Nanozymes in Cancer Phototherapy: Progress and Perspectives , 2021, Biomolecules.
[43] P. Kesharwani,et al. Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer. , 2021, International journal of pharmaceutics.
[44] G. Sulaiman,et al. Gold Nanoparticles and Graphene Oxide Flakes Enhance Cancer Cells’ Phagocytosis through Granzyme-Perforin-Dependent Biomechanism , 2021, Nanomaterials.
[45] Michael R Hamblin,et al. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. , 2021, Carbohydrate polymers.
[46] V. Vodnik,et al. Development of genistein-loaded gold nanoparticles and their antitumor potential against prostate cancer cell lines. , 2021, Materials science & engineering. C, Materials for biological applications.
[47] Jun Zhang,et al. Multifunctional ZnO@CuS nanoparticles cluster synergize chemotherapy and Photothermal therapy for tumor metastasis. , 2021, Nanomedicine : nanotechnology, biology, and medicine.
[48] M. Ashrafizadeh,et al. Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy. , 2021, Life sciences.
[49] Jianfeng Zhang,et al. Blood circulation stable doxorubicin prodrug nanoparticles containing hydrazone and thioketal moieties for antitumor chemotherapy. , 2021, Colloids and surfaces. B, Biointerfaces.
[50] T. Ouyang,et al. miR‐21 inhibition reverses doxorubicin‐resistance and inhibits PC3 human prostate cancer cells proliferation , 2021, Andrologia.
[51] J. Badger,et al. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients , 2021, Science.
[52] A. Desideri,et al. Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures , 2021, Cell death & disease.
[53] Dongsheng He,et al. A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy , 2020, Journal of Nanobiotechnology.
[54] S. Wilhelm,et al. Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells , 2020, Bioactive materials.
[55] S. Mowla,et al. Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles , 2018, Radiation Oncology.
[56] Chunxi Wang,et al. Gold nanoparticles regulate the antitumor secretome and have potent cytotoxic effects against prostate cancer cells , 2020, Journal of applied toxicology : JAT.
[57] A. Paulo,et al. Radiolabeled Gold Nanoparticles for Imaging and Therapy of Cancer , 2020, Materials.
[58] Chaoxing Zhang,et al. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer , 2020, Scientific Reports.
[59] R. Yuan,et al. Biodegradable nanoparticle-assisted and multiplexed imaging of asymmetric RNA expressions in live cells for precise cancer diagnosis and prognosis. , 2020, Nanoscale.
[60] Jingwei Tan,et al. Synthesis and Application of AS1411-Functionalized Gold Nanoparticles for Targeted Therapy of Gastric Cancer , 2020, ACS omega.
[61] JingBo Wu,et al. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy , 2020, International journal of nanomedicine.
[62] Xinyuan Zhu,et al. A Redox-Responsive, In-Situ Polymerized Polyplatinum(IV)-Coated Gold Nanorod as An Amplifier of Tumor Accumulation for Enhanced Thermo-Chemotherapy. , 2020, Biomaterials.
[63] Moganavelli Singh,et al. Cervical cancer: a meta-analysis, therapy and future of nanomedicine , 2020, Ecancermedicalscience.
[64] Xia Zhao,et al. Review on marine carbohydrate-based gold nanoparticles represented by alginate and chitosan for biomedical application. , 2020, Carbohydrate polymers.
[65] M. Mayo,et al. Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer , 2020, Cancer Research.
[66] D. Chithrani,et al. Advances in Gold Nanoparticle-Based Combined Cancer Therapy , 2020, Nanomaterials.
[67] V. Voliani,et al. Combined chemo-photothermal treatment of three-dimensional head and neck squamous cell carcinomas by gold nano-architectures. , 2020, Journal of colloid and interface science.
[68] Yutaka Suzuki,et al. Slow-Cycling Cancer Stem Cells Regulate Progression and Chemoresistance in Colon Cancer , 2020, Cancer Research.
[69] A. Dalpiaz,et al. Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? , 2020, Drug discovery today.
[70] Liangjie Hong,et al. Cancer cell membrane-coated gold nanorods for photothermal therapy and radiotherapy on oral squamous cancer. , 2020, Journal of materials chemistry. B.
[71] S. M. Taghdisi,et al. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells. , 2020, Carbohydrate polymers.
[72] L. You,et al. Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer. , 2020, American journal of cancer research.
[73] G. Chiosis,et al. Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer , 2020, Nature Biomedical Engineering.
[74] Xiaoping Zhou,et al. Nanoparticle-based co-delivery of siRNA and paclitaxel for dual-targeting of glioblastoma. , 2020, Nanomedicine.
[75] J. Qu,et al. Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy. , 2020, Biomaterials.
[76] Maha Alafeef,et al. Machine-learning for Precision Breast Cancer Diagnosis and Prediction of the Nanoparticles Cellular internalization. , 2020, ACS sensors.
[77] E. Khalil,et al. Gold Nanocomplex Strongly Modulates the PI3K/Akt Pathway and Other Pathways in MCF-7 Breast Cancer Cell Line , 2020, International journal of molecular sciences.
[78] A. Estella-Hermoso de Mendoza,et al. Nanomedicine and drug delivery systems in cancer and regenerative medicine. , 2020, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[79] Weilin Wang,et al. Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy , 2020, Theranostics.
[80] V. Feldman,et al. Controlled radiation-chemical synthesis of metal polymer nanocomposites in the films of interpolyelectrolyte complexes: Principles, prospects and implications , 2020 .
[81] Xing-jie Liang,et al. Ultrasmall gold nanoparticles in cancer diagnosis and therapy , 2020, Theranostics.
[82] M. Norouzi. Gold Nanoparticles in Glioma Theranostics. , 2020, Pharmacological research.
[83] Bangshang Zhu,et al. Development of a multifunctional gold nanoplatform for combined chemo-photothermal therapy against oral cancer. , 2020, Nanomedicine.
[84] Shiva Akbari-Birgani,et al. Cancer Therapy and Imaging Through Functionalized Carbon Nanotubes Decorated with Magnetite and Gold Nanoparticles as a Multimodal Tool , 2020, Applied Biochemistry and Biotechnology.
[85] A. Wu,et al. pH-Responsive metal-organic framework encapsulated gold nanoclusters with modulated release to enhance photodynamic therapy/chemotherapy in breast cancer. , 2020, Journal of materials chemistry. B.
[86] Seung‐Hwan Lee,et al. Doxorubicin-carboxymethyl xanthan gum capped gold nanoparticles: Microwave synthesis, characterization, and anti-cancer activity. , 2020, Carbohydrate polymers.
[87] D. Irvine,et al. Enhancing cancer immunotherapy with nanomedicine , 2020, Nature Reviews Immunology.
[88] A. R. Karikachery,et al. New Approaches in Breast Cancer Therapy Through Green Nanotechnology and Nano-Ayurvedic Medicine – Pre-Clinical and Pilot Human Clinical Investigations , 2020, International journal of nanomedicine.
[89] Elisabete C. Costa,et al. Hyaluronic acid and vitamin E polyethylene glycol succinate functionalized gold-core silica shell nanorods for cancer targeted photothermal therapy. , 2020, Colloids and surfaces. B, Biointerfaces.
[90] M. Singh,et al. Chitosan mediated gold nanoparticles against pathogenic bacteria, fungal strains and MCF-7 cancer cells. , 2020, International journal of biological macromolecules.
[91] A. Barzegari,et al. PEGylated gold nanoparticles-ribonuclease induced oxidative stress and apoptosis in colorectal cancer cells , 2019, BioImpacts : BI.
[92] O. Gbenebor,et al. Solubility, degree of acetylation, and distribution of acetyl groups in chitosan , 2020 .
[93] V. Thakur,et al. Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics. , 2019, International journal of biological macromolecules.
[94] Nokyoung Park,et al. Reversibly pH-responsive gold nanoparticles and their applications for photothermal cancer therapy , 2019, Scientific Reports.
[95] Neil Vasan,et al. A view on drug resistance in cancer , 2019, Nature.
[96] Junmin Qian,et al. Multifunctional PEG-b-polypeptide-decorated gold nanorod for targeted combined chemo-photothermal therapy of breast cancer. , 2019, Colloids and surfaces. B, Biointerfaces.
[97] Jon A. Schwartz,et al. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study , 2019, Proceedings of the National Academy of Sciences.
[98] Gal Chen,et al. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine , 2019, Advanced materials.
[99] Thanh Phuoc Nguyen,et al. Chitosan/fucoidan multilayer coating of gold nanorods as highly efficient near-infrared photothermal agents for cancer therapy. , 2019, Carbohydrate polymers.
[100] Kaili Hu,et al. Chitosan and chitosan coating nanoparticles for the treatment of brain disease , 2019, International journal of pharmaceutics.
[101] T. Bivona,et al. Polytherapy and Targeted Cancer Drug Resistance. , 2019, Trends in cancer.
[102] C. Blanpain,et al. EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.
[103] N. Zhao,et al. Versatile Types of Organic/Inorganic Nanohybrids: From Strategic Design to Biomedical Applications. , 2019, Chemical reviews.
[104] Jing Wang,et al. Dual targeted and pH-responsive gold nanorods with improved chemotherapy and photothermal ablation for synergistic cancer treatment , 2019, RSC advances.
[105] Jeung-Whan Han,et al. Targeting epigenetics for cancer therapy , 2019, Archives of Pharmacal Research.
[106] R. Qin,et al. Danthron suppresses autophagy and sensitizes pancreatic cancer cells to doxorubicin. , 2019, Toxicology in vitro : an international journal published in association with BIBRA.
[107] B. Klajnert-Maculewicz,et al. Gold Nanoparticles in Cancer Treatment. , 2018, Molecular pharmaceutics.
[108] Zahra Shariatinia,et al. Pharmaceutical applications of chitosan. , 2019, Advances in colloid and interface science.
[109] Junmin Qian,et al. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer. , 2018, Acta biomaterialia.
[110] Jiulong Zhang,et al. Dendrimer‐Stabilized Gold Nanoflowers Embedded with Ultrasmall Iron Oxide Nanoparticles for Multimode Imaging–Guided Combination Therapy of Tumors , 2018, Advanced science.
[111] Marjan Ghorbani,et al. A novel multi stimuli-responsive PEGylated hybrid gold/nanogels for co-delivery of doxorubicin and 6‑mercaptopurine. , 2018, Materials science & engineering. C, Materials for biological applications.
[112] Zhiqiang Yu,et al. Rational design of multi-stimuli-responsive gold nanorod-curcumin conjugates for chemo-photothermal synergistic cancer therapy. , 2018, Biomaterials science.
[113] Mingwu Shen,et al. Multifunctional Dendrimer-Entrapped Gold Nanoparticles Conjugated with Doxorubicin for pH-Responsive Drug Delivery and Targeted Computed Tomography Imaging. , 2018, Langmuir : the ACS journal of surfaces and colloids.
[114] Kemin Wang,et al. Self‐Assembled Supramolecular Nanoparticles for Targeted Delivery and Combination Chemotherapy , 2018, ChemMedChem.
[115] C. Rodríguez-Padilla,et al. Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production , 2018, International journal of nanomedicine.
[116] Changyou Gao,et al. Doxorubicin-conjugated pH-responsive gold nanorods for combined photothermal therapy and chemotherapy of cancer , 2018, Bioactive materials.
[117] Xu Zhen,et al. Dual‐Peak Absorbing Semiconducting Copolymer Nanoparticles for First and Second Near‐Infrared Window Photothermal Therapy: A Comparative Study , 2018, Advanced materials.
[118] Xiangyang Shi,et al. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy , 2018, Theranostics.
[119] Jun Chen,et al. miR-21-5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3 , 2018, International journal of molecular medicine.
[120] Jie Song,et al. pH-responsive gold nanoclusters-based nanoprobes for lung cancer targeted near-infrared fluorescence imaging and chemo-photodynamic therapy. , 2017, Acta biomaterialia.
[121] Zhigang Xie,et al. Near-infrared BODIPY-paclitaxel conjugates assembling organic nanoparticles for chemotherapy and bioimaging. , 2017, Journal of colloid and interface science.
[122] F. Slack,et al. Non-coding RNA networks in cancer , 2017, Nature Reviews Cancer.
[123] Krishan Kumar,et al. Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles. , 2017, Bioorganic & medicinal chemistry letters.
[124] G. Peters,et al. The potential of multi-compound nanoparticles to bypass drug resistance in cancer , 2017, Cancer Chemotherapy and Pharmacology.
[125] Junliang Yang,et al. Polypeptide-Engineered Hydrogel Coated Gold Nanorods for Targeted Drug Delivery and Chemo-photothermal Therapy. , 2017, ACS biomaterials science & engineering.
[126] W. Wang,et al. Unique Roles of Gold Nanoparticles in Drug Delivery, Targeting and Imaging Applications , 2017, Molecules.
[127] C. Patra,et al. Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer. , 2017, Journal of materials chemistry. B.
[128] Jufang Wang,et al. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics. , 2017, Acta biomaterialia.
[129] A. Jose,et al. Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles. , 2017, International journal of pharmaceutics.
[130] Honglei Zhan,et al. A new targeted delivery approach by functionalizing drug nanocrystals through polydopamine coating , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[131] Marjan Ghorbani,et al. Redox and pH-responsive gold nanoparticles as a new platform for simultaneous triple anti-cancer drugs targeting. , 2017, International journal of pharmaceutics.
[132] I. Aoki,et al. Hyperthermia and chemotherapy using Fe(Salen) nanoparticles might impact glioblastoma treatment , 2017, Scientific Reports.
[133] Min Zhang,et al. Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin , 2017, International journal of molecular sciences.
[134] Yan-ru Ge,et al. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin. , 2017, Molecular pharmaceutics.
[135] Jing-Juan Xu,et al. Two-photon excitation nanoparticles for photodynamic therapy. , 2016, Chemical Society reviews.
[136] Nhat Quang Bui,et al. Paclitaxel-loaded chitosan oligosaccharide-stabilized gold nanoparticles as novel agents for drug delivery and photoacoustic imaging of cancer cells. , 2016, International journal of pharmaceutics.
[137] Dejian Zhou,et al. pH and near-infrared light dual-stimuli responsive drug delivery using DNA-conjugated gold nanorods for effective treatment of multidrug resistant cancer cells. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[138] A. Bernstein,et al. Sustained release of rhBMP-2 from microporous tricalciumphosphate using hydrogels as a carrier , 2016, BMC Biotechnology.
[139] Jianguo Tian,et al. Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[140] Mengjiao Zhou,et al. Shape regulated anticancer activities and systematic toxicities of drug nanocrystals in vivo. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[141] M. Kamal,et al. Solid Matrix Based Lipidic Nanoparticles in Oral Cancer Chemotherapy: Applications and Pharmacokinetics. , 2015, Current drug metabolism.
[142] H. Yoon,et al. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA , 2015, Theranostics.
[143] Aleksandra Markovets,et al. Acquired EGFR C797S mediates resistance to AZD9291 in advanced non-small cell lung cancer harboring EGFR T790M , 2015, Nature Medicine.
[144] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[145] F. Davi,et al. CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans , 2015, PLoS medicine.
[146] K. Soo,et al. Nanoparticles in photodynamic therapy. , 2015, Chemical reviews.
[147] D Andrews,et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 , 2014, Cell Death and Differentiation.
[148] Teh-Hua Tsai,et al. Trends of Gold Nanoparticle-based Drug Delivery System in Cancer Therapy , 2014 .
[149] Molly M. Stevens,et al. Colloidal nanoparticles as advanced biological sensors , 2014, Science.
[150] Lingrong Liu,et al. Chitosan-coated gold nanorods for cancer therapy combining chemical and photothermal effects. , 2014, Macromolecular bioscience.
[151] U. Krishnan,et al. Development of a dual nanocarrier system as a potential stratagem against amyloid-induced toxicity , 2014, Expert opinion on drug delivery.
[152] R. Banerjee,et al. Biphasic magnetic nanoparticles-nanovesicle hybrids for chemotherapy and self-controlled hyperthermia. , 2014, Nanomedicine.
[153] William Pao,et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. , 2014, Cancer discovery.
[154] Solmaz Maleki Dizaj,et al. A sight on the current nanoparticle-based gene delivery vectors , 2014, Nanoscale Research Letters.
[155] J. Mesirov,et al. A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. , 2014, Cancer discovery.
[156] Andrew Z. Wang,et al. Nanoparticles and their applications in cell and molecular biology. , 2014, Integrative biology : quantitative biosciences from nano to macro.
[157] Ying-Wei Yang,et al. Gold nanoparticles functionalized with supramolecular macrocycles , 2013 .
[158] A. Florea,et al. One-step synthesis of pegylated gold nanoparticles with tunable surface charge , 2013 .
[159] Wenjin Xu,et al. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy. , 2012, Nanoscale.
[160] Melonie P. Heron,et al. Deaths: leading causes for 2009. , 2012, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[161] O. Moșteanu,et al. Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells. , 2012, Journal of gastrointestinal and liver diseases : JGLD.
[162] Sarit S. Agasti,et al. Gold nanoparticles in chemical and biological sensing. , 2012, Chemical reviews.
[163] Jianfeng Han,et al. Paclitaxel-loaded tocopheryl succinate-conjugated chitosan oligosaccharide nanoparticles for synergistic chemotherapy , 2012 .
[164] M. Nöthen,et al. A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer , 2012, Nature Medicine.
[165] V. Rotello,et al. Gold nanoparticles: preparation, properties, and applications in bionanotechnology. , 2012, Nanoscale.
[166] H. Hieronymus,et al. FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR , 2011, Nature.
[167] T. Srinophakun,et al. Preliminary Study of Conformation and Drug Release Mechanism of Doxorubicin-Conjugated Glycol Chitosan, via cis-Aconityl Linkage, by Molecular Modeling , 2011, International journal of molecular sciences.
[168] Wenbin Lin,et al. Nanoscale Metal–Organic Frameworks: Magnetic Resonance Imaging Contrast Agents and Beyond , 2010 .
[169] Chun Li,et al. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. , 2010, ACS nano.
[170] T. Baumann,et al. Surface Chemistry in Nanoscale Materials , 2009, Materials.
[171] M. Prabaharan,et al. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. , 2009, Biomaterials.
[172] Vincent M. Rotello,et al. Multimodal drug delivery using gold nanoparticles. , 2009, Nanoscale.
[173] Priyabrata Mukherjee,et al. Biological properties of "naked" metal nanoparticles. , 2008, Advanced drug delivery reviews.
[174] Yih-Leong Chang,et al. Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Mutations Is Associated with Poor Gefitinib Treatment Response , 2008, Clinical Cancer Research.
[175] M. Meyerson,et al. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP , 2008, Proceedings of the National Academy of Sciences.
[176] Michihiro Nakamura,et al. Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles , 2007, International journal of cancer.
[177] Ji-Xin Cheng,et al. Hyperthermic effects of gold nanorods on tumor cells. , 2007, Nanomedicine.
[178] R. England,et al. Review of xanthan gum production from unmodified starches by Xanthomonas comprestris sp. , 2006 .
[179] C. Murphy,et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.
[180] M. Izquierdo. Short interfering RNAs as a tool for cancer gene therapy , 2005, Cancer Gene Therapy.
[181] M. Meyerson,et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. , 2005, The New England journal of medicine.
[182] S. Ghosh,et al. General method of synthesis for metal nanoparticles , 2004 .
[183] S. Kaye,et al. The multidrug resistance phenotype. , 1988, British Journal of Cancer.
[184] N. Geller,et al. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[185] W. Hryniuk,et al. The importance of dose intensity in chemotherapy of metastatic breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[186] V. Devita,et al. Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. , 1980, Annals of internal medicine.
[187] G. Bonadonna,et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. , 1976, The New England journal of medicine.
[188] J. Crofton. Chemotherapy in Pulmonary Tuberculosis , 1954, Edinburgh medical journal.